A cross-sectional study on the characteristics and distribution of acupoint sensitization in patients with chronic coronary syndrome
- Conditions
- Chronic coronary syndrome
- Registration Number
- ITMCTR2024000102
- Lead Sponsor
- Shaanxi University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
For patients with chronic coronary syndromes:
(1) meet the diagnostic criteria of chronic coronary syndrome;
(2) Patients were not limited in activity, with clear answers and good compliance;
(3) 18= 85 years old, male or female;
(4) those who voluntarily signed the informed consent;
Healthy subjects:
(1) 18= age =85 years old, male or female;
(2) no history of chronic coronary syndrome or other heart diseases;
(3) No obvious discomfort symptoms, clear answers, good compliance;
(4) those who voluntarily signed the informed consent;
For patients with chronic coronary syndromes:
(1) there are serious arrhythmia, heart failure, valvular heart disease, congenital heart disease, primary cardiomyopathy, aortic dissection, and other heart disease, and patients with severe cerebrovascular disease;
(2) patients with malignant tumors, severe hematological diseases, severe liver and kidney dysfunction, and mental disorders who are unable to cooperate;
(3) has a tendency to bleeding or allergic constitution;
(4) patients with severe osteoporosis;
(5) pain in shoulder, back and arm caused by muscle strain, myofasciitis, cervical spine and thoracic spine lesions;
(6) detection area skin damage of the operator,
(7) pregnant and lactating women;
(8) those who participated or are participating in other clinical trials within the past 3 months.
Healthy subjects:
(1) during pregnancy and lactation women;
(2) the skin damage of the exploration area affects the operator;
(3) for nearly three months had attended or is in other clinical subjects.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method